Association between visual impairment and cognitive disorders in low-and-middle income countries: a systematic review.


Journal

Aging & mental health
ISSN: 1364-6915
Titre abrégé: Aging Ment Health
Pays: England
ID NLM: 9705773

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 9 9 2020
medline: 12 10 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

Visual impairment and cognitive disorders are common among older people in Low-and Middle-Income Countries (LMIC). Several recent studies performed in High-Income Countries suggested that visual impairment is associated with cognitive disorders. However, no synthesis of current knowledge exists for LMIC. We have conducted an extensive literature search combining six databases and two grey literature databases. We searched for studies assessing the link between visual and cognitive impairments carried out in LMIC. The systematic search was performed up to 14th February 2019. Overall, eight studies were included in this review. Among them, five studies were performed in Asia and seven studies had a cross-sectional design. Mean age of the participants varied from 64.2 to 76.2 years. Participants were most often females. Only three studies were specifically focused on the association between visual impairment and cognitive disorders. Out of the eight studies included, four reported a significant association; two showed a possible association and two did not retrieve any statistically significant effect. Heterogeneity in assessments of visual and cognitive impairments was high. In LMIC, very few studies explored the association between visual and cognitive impairments among older people. The current review seems to suggest that visual impairment is associated with cognitive disorders in LMIC. However, further studies are required to improve the knowledge on this relationship. Improving vision, in particular through optical correction and cataract surgery, could potentially be easy pathways to reduce cognitive disorders incidence and to improve quality of life of people affected by this disorder.

Identifiants

pubmed: 32896159
doi: 10.1080/13607863.2020.1808878
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1786-1795

Auteurs

Antoine Gbessemehlan (A)

INSERM U 1094 Institute of Epidemiology and Tropical Neurology, University of Limoges, Limoges, France.
IRD Associated Unit Tropical Neuroepidemiology, University of Limoges, Limoges, France.

Maëlenn Guerchet (M)

INSERM U 1094 Institute of Epidemiology and Tropical Neurology, University of Limoges, Limoges, France.
IRD Associated Unit Tropical Neuroepidemiology, University of Limoges, Limoges, France.

Catherine Helmer (C)

INSERM U1219 Bordeaux Population Health Research Center Team LEHA, University of Bordeaux, Bordeaux, France.

Cecile Delcourt (C)

INSERM U1219 Bordeaux Population Health Research Center Team LEHA, University of Bordeaux, Bordeaux, France.

Dismand Houinato (D)

INSERM U 1094 Institute of Epidemiology and Tropical Neurology, University of Limoges, Limoges, France.
IRD Associated Unit Tropical Neuroepidemiology, University of Limoges, Limoges, France.

Pierre-Marie Preux (PM)

INSERM U 1094 Institute of Epidemiology and Tropical Neurology, University of Limoges, Limoges, France.
IRD Associated Unit Tropical Neuroepidemiology, University of Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH